Is the new Wilson LIC, WAM Strategic Value (ASX:WAR) a buy?
Whilst WAM has proven form using the underlying investment strategies planned for this new LIC, there are a few reasons why I would be cautious about jumping in. The performance fee is high, opportunities for this overall strategy have dried up somewhat compared to last year, and then there are the usual potential issues of buying LICs at IPO.
Continue reading “WHICH LICs WILL WAM GO TO WAR ON? WAM STRATEGIC VALUE REVIEW (ASX:WAR)”
I expect on balance discounts on LICs to continue to contract in 2021, mainly due to a lack of supply. It is therefore no surprise that I am not expecting a great deal of LIC IPO activity next year. There was controversy surrounding sales commissions and LIC IPOs that got plenty of attention in 2019. (This was after a flood of new issuance in the few years prior, with many poor performers). For this reason, I do not think financial planners and investors have great appetite yet to take the plunge into new closed end fund products.
Continue reading “ASX LIC TRENDS FOR 2021 IN TERMS OF DISCOUNTS / PREMIUMS & POTENTIAL IPOs”
I realise many of the readers here may already have come across this article from Daryl Wilson at Affluence Funds Management but felt it was worth a mention. This fund manager specialises in ASX LICs. I tend to agree with many of their views in articles I come across and this was no exception. I thought I would just comment further down about how some of the themes they brought up in the article may be impacting my own decision making. Continue reading “A good reminder on some themes to consider in LIC’s over the next year.”
I have commented on the CYA situation numerous times on the blog. One of the reasons I started blogging is I find it a useful discipline to force me to go back and look at my notes when I entered a stock. I first purchased CYA in September last year thinking that over the next year or two it was highly likely Wilson would gain control. Continue reading “WAM CAPITAL, RECENT WILSON LIC PERFORMANCE, WAM MICROCAP”